Home
>
US Stocks
>
Provention Bio Inc
Provention Bio Inc
PRVB

Provention Bio Inc (PRVB)

$6.190.32%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$6.32
Today Low/High$6.18 / $6.39
52 Week Low/High$5.59 / $20.05
Market Cap$395.46M

Company Details

Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed by the U.S. Food and Drug Administration (FDA). The Company's pipeline includes additional clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in other autoimmune diseases, including celiac disease and lupus.
OrganisationProvention Bio Inc
HeadquatersRed Bank, New Jersey, US
Employees59
IndustryHealth Technology
CEOAshleigh Palmer

Discover more

Frequently Asked Questions

What is Provention Bio Inc (PRVB) share price today?

Can Indians buy Provention Bio Inc (PRVB) shares?

How can I buy Provention Bio Inc (PRVB) shares from India?

Can Fractional shares of Provention Bio Inc (PRVB) be purchased?

What are the documents required to start investing in Provention Bio Inc (PRVB) stocks?

We are a SEBI registered investement advisor